V
CRL icon

Veritable’s Charles River Laboratories CRL Stock Holding History

Veritable’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-586
Closed -$221K – 918
2021
Q4 		$221K Sell
586
-42
-7% -$16.3K ﹤0.01% 847
2021
Q3 		$259K Sell
628
-30
-5% -$12.5K ﹤0.01% 748
2021
Q2 		$243K Sell
658
-96
-13% -$32.1K ﹤0.01% 758
2021
Q1 		$219K Buy
+754
New +$210K ﹤0.01% 764
2018
Q3 		– Sell
-2,640
Closed -$296K – 829
2018
Q2 		$296K Buy
2,640
+322
+14% +$34.8K 0.01% 640
2018
Q1 		$247K Buy
+2,318
New +$250K 0.01% 690

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Veritable's CRL Position: Q1 2022 in Review

Veritable sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 586 shares — an estimated $221K sold.

Veritable first reported a position in CRL in Q1 2018 and held it in 6 quarters. The position peaked at $296K in Q2 2018. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • Veritable reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • Veritable sold 586 Charles River Laboratories shares in Q1 2022, an estimated $221K.
  • Veritable first reported a position in Charles River Laboratories in Q1 2018 and held it in 6 quarters.
  • Veritable's Charles River Laboratories position peaked at $296K in Q2 2018.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on Veritable's 13F filing for Q1 2022, filed 11 May 2022.